TipRanks
Go Ultimate55% OFF

Galectin Therapeutics (PHPN) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

PHPN Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Galectin Therapeutics in the past 3 months

PHPN Stock 12 Month Forecast

EUR 9.82▲(245.82% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Galectin Therapeutics in the last 3 months. The average price target is EUR 9.82 with a high forecast of EUR 9.82 and a low forecast of EUR 9.82. The average price target represents a 245.82% change from the last price of EUR 2.84.
Highest Price TargetEUR 9.82Average Price TargetEUR 9.82Lowest Price TargetEUR 9.82

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:PHPN
Price TargetFollowArticle
H.C. WainwrightEUR 9.82buy245.82%UpsideReiterated08/14/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Galectin Therapeutics

3 Months
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate5/8 ratings generated profit
63%
Average Return
+14.06%

Copying Matthew Keller's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +14.06% per trade.

1 Year
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate5/8 ratings generated profit
63%
Average Return
+1.65%

Copying Matthew Keller's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +1.65% per trade.

2 Years
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate5/8 ratings generated profit
63%
Average Return
+5.85%

Copying Matthew Keller's trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +5.85% per trade.

PHPN Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for PHPN
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy44211
Buy00000
Hold00000
Sell00000
Strong Sell00000
total44211

In the current month, PHPN has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PHPN average Analyst price target in the past 3 months is 9.82.

PHPN Financial Forecast

EUR -2EUR -1.5EUR -1EUR -0.5EUR 0Q4 2025Q2 2026Q3 2026
HighEUR -0.04
ConsensusEUR -0.04
LowEUR -0.04

PHPN Earnings Forecast

Next quarter’s earnings estimate for PHPN is -EUR 0.04 with a range of -EUR 0.04 to -EUR 0.04. The previous quarter’s EPS was -EUR 0.13. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR -1EUR -0.5EUR 0EUR 0.5EUR 1Q4 2025Q2 2026Q3 2026
HighEUR 0.00
ConsensusEUR 0.00
LowEUR 0.00

PHPN Sales Forecast

Next quarter’s sales forecast for PHPN is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

PHPN Stock Forecast FAQ

What is DE:PHPN’s average 12-month price target, according to analysts?
Based on analyst ratings, Galectin Therapeutics’s 12-month average price target is €9.82.
What is DE:PHPN’s upside potential, based on the analysts’ average price target?
Galectin Therapeutics has 245.82% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Galectin Therapeutics a Buy, Sell or Hold?
Galectin Therapeutics has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Galectin Therapeutics’s share price target?
The average share price target for Galectin Therapeutics is €9.82. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €9.82, and the lowest forecast is €9.82. The average share price target represents a 245.82% increase from the current price of €2.84.
What do analysts say about Galectin Therapeutics?
Galectin Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Galectin Therapeutics?
To buy shares of DE:PHPN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.